Foxo3a expression is a prognostic marker in breast cancer.
about
Regulation of Bim in Health and DiseaseProlyl hydroxylation by EglN2 destabilizes FOXO3a by blocking its interaction with the USP9x deubiquitinase.Reprogramming ovarian and breast cancer cells into non-cancerous cells by low-dose metformin or SN-38 through FOXO3 activationMicroRNA-96 inhibits FoxO3a function in IPF fibroblasts on type I collagen matrix.Evaluating the evidence for targeting FOXO3a in breast cancer: a systematic review.Increased expression of forkhead box M1 is associated with aggressive phenotype and poor prognosis in estrogen receptor-positive breast cancer.Globular Adiponectin Causes Tolerance to LPS-Induced TNF-α Expression via Autophagy Induction in RAW 264.7 Macrophages: Involvement of SIRT1/FoxO3A AxisActivation of FOXO3a suggests good prognosis of patients with radically resected gastric cancerTumor suppressive effect of PARP1 and FOXO3A in gastric cancers and its clinical implicationsBRCA1 positively regulates FOXO3 expression by restricting FOXO3 gene methylation and epigenetic silencing through targeting EZH2 in breast cancerMultiplex Gene Expression Profiling of 16 Target Genes in Neoplastic and Non-Neoplastic Canine Mammary Tissues Using Branched-DNA Assay.Pharmacological activation of FOXO3 suppresses triple-negative breast cancer in vitro and in vivoIdentification of upstream transcription factors (TFs) for expression signature genes in breast cancer.FOXO3a Expression Regulated by ERK Signaling is Inversely Correlated With Y-Box Binding Protein-1 Expression in Prostate Cancer.Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a.Expression of microRNA-96 and its potential functions by targeting FOXO3 in non-small cell lung cancer.A novel FOXA1/ESR1 interacting pathway: A study of Oncomine™ breast cancer microarrays.NEDD4-induced degradative ubiquitination of phosphatidylinositol 4-phosphate 5-kinase α and its implication in breast cancer cell proliferation.Antitumor activity of arsenite in combination with tetrandrine against human breast cancer cell line MDA-MB-231 in vitro and in vivo
P2860
Q26781203-FD5EDBB8-D031-4D64-BA86-1F1BCBAA2494Q33850553-8EFFADB7-9BE0-43BC-8B03-B3D53DAE0F45Q33942068-97BBBF5C-FB6C-46BB-B555-7A035E1B9166Q34356445-F5753465-0CEF-4470-A92A-A4E4B4D738D5Q35077393-6DBF790E-BCFA-44CE-AAE5-B1A691F37358Q35198542-E6819A49-C012-407C-AD3D-ED0A94459C75Q35626616-6E3FA306-6AE4-4BDD-8A5C-F7E4360A6D2DQ35632231-F580D466-0571-4CF3-A2A6-BE8620FDFF1EQ36689103-54F2939F-DCA2-48D8-8620-069AB828131FQ36846719-CF02DD0B-0B2D-4E5A-9E14-3ECECCD98D53Q37286664-8ED5CC36-6471-4CA6-A23A-C69F885FCB1EQ37520463-142DB41E-FD1E-4CAE-8502-C0A9304606FBQ38440765-99E8C449-2641-48A4-B29A-75979FD9AD12Q38742577-20362DAE-D728-4ECE-9338-DC1AC83D96E2Q38817904-42FB8E00-9F9F-40D7-AA87-AFCFC57A34ECQ38950194-C859E065-9CA9-48A7-9990-133E94E233C2Q40090503-78965F8F-D5CA-4671-AF98-E8283BCD25FFQ54977561-14133EFA-D257-4757-97F3-2D2C17A931E3Q58786173-CAD9EB83-053C-4F4E-B57E-51BA8F6D418C
P2860
Foxo3a expression is a prognostic marker in breast cancer.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Foxo3a expression is a prognostic marker in breast cancer.
@ast
Foxo3a expression is a prognostic marker in breast cancer.
@en
Foxo3a expression is a prognostic marker in breast cancer.
@nl
type
label
Foxo3a expression is a prognostic marker in breast cancer.
@ast
Foxo3a expression is a prognostic marker in breast cancer.
@en
Foxo3a expression is a prognostic marker in breast cancer.
@nl
prefLabel
Foxo3a expression is a prognostic marker in breast cancer.
@ast
Foxo3a expression is a prognostic marker in breast cancer.
@en
Foxo3a expression is a prognostic marker in breast cancer.
@nl
P2093
P2860
P1433
P1476
Foxo3a expression is a prognostic marker in breast cancer.
@en
P2093
P2860
P304
P356
10.1371/JOURNAL.PONE.0070746
P407
P577
2013-08-13T00:00:00Z